CD8A and neoplasm: The preclinical results reported here demonstrate that the combination of IRE and anti-PD1 promoted tumor infiltration by CD8+ cytotoxic T cells without recruiting other immunosuppressive cells, and significantly prolonged survival in an orthotopic murine PDAC model.